PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Pretreatment with bone marrow-derived mesenchymal stromal cell-conditioned media confers pulmonary ischemic tolerance.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26896360 ↗2015Reported benefit

Pretreatment with bone marrow-derived mesenchymal stromal cell-conditioned media confers pulmonary ischemic tolerance.

RatIschaemia-reperfusionOther / unspecifiedLong-Evans (pathogen-free, Harlan Sprague-Dawley)Malen = n=10 per conditioned media clone group; n=15 media-only con…Intratracheal instillation200 microlitres of conditioned media per animal30 minutes before ischaemia (pretreatment)

Model: Left lung warm ischaemia-reperfusion: left hilar non-crushing clamp for 90 minutes followed by 4 hours of reventilation and reperfusion

Five of seven conditioned media clones reduced injury severity; clones O and H gave the largest reduction in lung permeability (median 0.086, p=0.0021 and p=0.028). Protective conditioned media significantly reduced BAL IL-1 beta and TNF alpha (both p<0.0001) and absolute neutrophil counts (p=0.000…

Extraction: extract · Supplied extraction confidence: 0.93. Machine-extracted fields require source verification.